The Clinical Use and Insurance of Biosimilars in the US ——Taking the Pfizer vs. Johnson Lawsuit as an Example

DONG Xin-yue,JIANG Rong,LIZHA Adelietibieke,SHAO Rong

PDF(849 KB)

China Biotechnology ›› 2019, Vol. 39 ›› Issue (12) : 95-102. DOI: 10.13523/j.cb.20191212

The Clinical Use and Insurance of Biosimilars in the US ——Taking the Pfizer vs. Johnson Lawsuit as an Example

Author information +

History +

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2019, 39(12): 95-102 https://doi.org/10.13523/j.cb.20191212

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

PDF(849 KB)

Accesses

Citation

Detail

Sections

Recommended